US$ 23.07
gland pharma glp-1 manufacturing india India's pharmaceutical industry is witnessing another massive strategic move ππ Anupam Rasayan plans to acquire up to 43% stake in Bliss GVS in a βΉ1,369 crore deal, signaling stronger expansion, integrated Leading Injectable Pharmaceutical Company |
Description
Semaglutide was removed in February 2025

Nutr Diabetes

From the approval of Orlistat (Xenical) in 1999, which focused on reducing dietary fat absorption, to the emergence of highly effective incretin-based therapies such as liraglutide (Saxenda), semaglutide (Wegovy), and tirzepatide (Zepbound), we have witnessed a fundamental shift in how obesity is understood and treated

Secondary outcomes included time below and above the therapeutic range and INR variability

.

Looking for Tirzepatide or Semaglutide near you
